Thomas Andersson
Corporate Officer/Principal at KAROLINSKA DEVELOPMENT AB
Profile
Thomas B.
Andersson is currently a Director at Skogsmöllan AB, Kongsberg Beam Technology AS, and Investment Manager at Karolinska Development AB.
He was previously the Chief Executive Officer at SpectraCure AB, Annexin Pharmaceuticals AB, and Lund University Bioscience AB from 2007 to 2012.
He was also the Chairman at ProNoxis AB and Director at DermaGen AB.
Dr. Andersson holds a graduate and doctorate degree from the University of Lund.
Thomas Andersson active positions
| Companies | Position | Start |
|---|---|---|
| KAROLINSKA DEVELOPMENT AB | Corporate Officer/Principal | - |
Kongsberg Beam Technology AS
 Kongsberg Beam Technology AS Miscellaneous Commercial ServicesCommercial Services Kongsberg Beam Technology AS develops and provides solutions for precise therapeutic radiation. The company was founded on August 2, 2005 and is headquartered in Kongsberg, Norway. | Director/Board Member | - |
Skogsmöllan AB
 Skogsmöllan AB Pharmaceuticals: MajorHealth Technology Skogsmöllan AB is a private company based in Veberod, Sweden. The Swedish company provides pharmaceutical preparation services. | Director/Board Member | - |
Former positions of Thomas Andersson
| Companies | Position | End |
|---|---|---|
| ISOFOL MEDICAL AB | Chief Executive Officer | 2023-06-20 |
Lund University Bioscience AB
 Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences. | Chief Executive Officer | 2012-12-30 |
| ANNEXIN PHARMACEUTICALS AB | Chief Executive Officer | - |
| SPECTRACURE AB | Chief Executive Officer | - |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Chairman | - |
Training of Thomas Andersson
| University of Lund | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| SPECTRACURE AB | Electronic Technology |
| ISOFOL MEDICAL AB | Health Technology |
| KAROLINSKA DEVELOPMENT AB | Finance |
| ANNEXIN PHARMACEUTICALS AB | Health Technology |
| Private companies | 5 |
|---|---|
Lund University Bioscience AB
Lund University Bioscience AB Investment ManagersFinance Lund University Bioscience AB (LU Bio) is an investment firm located in Lund, Sweden. In May 2007, LU Bio was founded by the parent firm, Lund University Development AB. They specialize in early-stage investments within the life sciences segment. Lund University was founded by the Swedish government in 1666. The university has three main research areas: medicine and pharmaceuticals, globally sustainable societal development, and the life sciences. | Finance |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
Skogsmöllan AB
Skogsmöllan AB Pharmaceuticals: MajorHealth Technology Skogsmöllan AB is a private company based in Veberod, Sweden. The Swedish company provides pharmaceutical preparation services. | Health Technology |
Kongsberg Beam Technology AS
Kongsberg Beam Technology AS Miscellaneous Commercial ServicesCommercial Services Kongsberg Beam Technology AS develops and provides solutions for precise therapeutic radiation. The company was founded on August 2, 2005 and is headquartered in Kongsberg, Norway. | Commercial Services |
DermaGen AB
 DermaGen AB Pharmaceuticals: MajorHealth Technology DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden. | Health Technology |
- Stock Market
- Insiders
- Thomas Andersson